Both in Pharmaceuticals
Tilray Brands vs Phathom Pharmaceuticals
Over the past year TLRY returned −80.9% and PHAT returned −44.2%; their daily moves had a correlation of -0.00.
TLRY −80.9% PHAT −44.2%Growth of $1, one year, split-adjusted
| Metric | TLRY | PHAT |
|---|---|---|
| Price | $3.21 | $7.50 |
| Market cap | $474.4M | $606.8M |
| Today | +2.23% | +1.35% |
| 1 month | −18.3% | −2.5% |
| 6 months | −52.7% | −40.5% |
| Year to date | −64.5% | −54.8% |
| 1 year | −79.9% | −40.0% |
| Revenue growth (YoY) | +22.7% | +88.0% |
| Gross margin | 30.1% | 79.7% |
| Net margin | −16.8% | −23.7% |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | 2.5× |
| Net cash | $16.6M | $16.5M |
| Dividend yield | — | — |
| Volatility (60d) | 51.0% | 75.3% |
| Short % of float | 12.7% | 18.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).